Age-related and regional differences in dopamine transporter mRNA expression in human midbrain
- PMID: 9109886
- DOI: 10.1212/wnl.48.4.969
Age-related and regional differences in dopamine transporter mRNA expression in human midbrain
Abstract
We assessed the abundance of dopamine transporter messenger RNA (DAT mRNA) in various human midbrain dopamine cell groups using in situ hybridization. The youngest individuals studied (17-23 years of age) exhibited significant regional heterogeneity of DAT expression, both in terms of the number of dopamine neurons expressing DAT mRNA and the abundance of DAT mRNA per cell, with the highest levels of expression evident within the ventral tier of the substantia nigra and lowest expression within the retrorubral field. In the older subjects (65-72 years old) analyzed, DAT mRNA in all regions was reduced to the level seen in the retrorubal field, indicating a positive correlation between initial levels of DAT expression and subsequent age-related reductions, with some regions exhibiting up to a 75% loss of DAT mRNA with age. The age-related decline in DAT mRNA was due to both a decrease in the abundance of DAT mRNA per dopamine cell as well as a decrease in the total number of dopamine cells expressing DAT mRNA, although tyrosine hydroxylase expression was less affected. These results indicate that changes in dopamine neurotransmission seen in normal aging may be related to altered DAT gene expression.
Similar articles
-
Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.J Neurosci Res. 2001 Aug 1;65(3):254-66. doi: 10.1002/jnr.1149. J Neurosci Res. 2001. PMID: 11494360
-
Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.J Comp Neurol. 1995 Nov 20;362(3):400-10. doi: 10.1002/cne.903620308. J Comp Neurol. 1995. PMID: 8576447
-
Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.Brain Res Mol Brain Res. 1994 Mar;22(1-4):29-38. doi: 10.1016/0169-328x(94)90029-9. Brain Res Mol Brain Res. 1994. PMID: 7912404
-
Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.Mov Disord. 1997 Nov;12(6):885-97. doi: 10.1002/mds.870120609. Mov Disord. 1997. PMID: 9399211
-
Molecular mechanisms involved in transport and release of dopamine in primary cultures of mesencephalic neurons.Neurochem Int. 1992 Mar;20 Suppl:101S-105S. doi: 10.1016/0197-0186(92)90219-h. Neurochem Int. 1992. PMID: 1365405 Review. No abstract available.
Cited by
-
Age-mediated transcriptomic changes in adult mouse substantia nigra.PLoS One. 2013 Apr 30;8(4):e62456. doi: 10.1371/journal.pone.0062456. Print 2013. PLoS One. 2013. PMID: 23638090 Free PMC article.
-
Intersection between metabolic dysfunction, high fat diet consumption, and brain aging.J Neurochem. 2010 Jul;114(2):344-61. doi: 10.1111/j.1471-4159.2010.06803.x. Epub 2010 May 6. J Neurochem. 2010. PMID: 20477933 Free PMC article. Review.
-
The Human LRRK2 Modulates the Age-Dependent Effects of Developmental Methylmercury Exposure in Caenorhabditis elegans.Neurotox Res. 2022 Oct;40(5):1235-1247. doi: 10.1007/s12640-022-00547-x. Epub 2022 Jul 15. Neurotox Res. 2022. PMID: 35838907
-
Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia.Front Psychiatry. 2019 May 28;10:314. doi: 10.3389/fpsyt.2019.00314. eCollection 2019. Front Psychiatry. 2019. PMID: 31214054 Free PMC article. Review.
-
Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder.Nat Commun. 2023 Sep 12;14(1):5610. doi: 10.1038/s41467-023-41455-8. Nat Commun. 2023. PMID: 37699936 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical